SN

Sasmita Nayak

Active Director Director DIN 08131457
DIN 08131457 First appointment May 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since May 2018
Shareholding value •••• Premium profile

About Sasmita Nayak

Data last updated:

Sasmita Nayak is a Director at Aal Biosciences Research Private Limited (since 2021), Director at Aal Research And Solution Private Limited (since 2018) and Director at S2i Institute Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Healthcare, Media and Publishing and Biotechnology. The 2 current companies with reported revenue have a combined latest revenue of ₹4.93 Cr; the largest is Aal Biosciences Research Private Limited at ₹3.23 Cr (FY 2024). Earlier, Sasmita Nayak was a Director at Aal Learnings & Analytics Private Limited (2021–2023).

DIN 08131457
Primary Designation Director
Industry Healthcare
First Appointment 11 May 2018
Oldest Company Age 8 yrs
Largest company Aal Biosciences Research Private Limited · ₹3.23 Cr (FY 2024)
Combined revenue ₹4.93 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Feb 20212021₹3.23 Cr (FY 2024)Active
Director11 May 20182018₹1.69 Cr (FY 2024)Active
S2i Institute Private Limited U73200HR2025PTC131614
Director05 May 20252025Active
Medvin Bio Solutions Private Limited U82990HR2025PTC128084
Director29 Jan 20252025Active
O2a Healthcare Private Limited U86900HR2024PTC124275
Director16 Aug 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Dec 20212021₹3.2 Lakh (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aal Biosciences Research Private Limited
Aal Research And Solution Private Limited
S2i Institute Private Limited
Medvin Bio Solutions Private Limited
Premium access

Shareholding and investment profile for Sasmita Nayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sasmita Nayak

Sasmita Nayak currently holds 5 directorships: Aal Biosciences Research Private Limited (Director, since 04 Feb 2021, revenue ₹3.23 Cr (FY 2024)); Aal Research And Solution Private Limited (Director, since 11 May 2018, revenue ₹1.69 Cr (FY 2024)); S2i Institute Private Limited (Director, since 05 May 2025); Medvin Bio Solutions Private Limited (Director, since 29 Jan 2025); O2a Healthcare Private Limited (Director, since 16 Aug 2024).

Sasmita Nayak was first appointed on 11 May 2018 as Director at Aal Research And Solution Private Limited. The most recent appointment on record is 05 May 2025 at S2i Institute Private Limited.

The 2 current companies of Sasmita Nayak that report revenue have a combined latest revenue of ₹4.93 Cr: Aal Biosciences Research Private Limited ₹3.23 Cr (FY 2024); Aal Research And Solution Private Limited ₹1.69 Cr (FY 2024).

Sasmita Nayak held 1 earlier board appointment: Aal Learnings & Analytics Private Limited (Director, 13 Dec 2021 to 03 Mar 2023).

The current boards of Sasmita Nayak's companies include Avipsa Priyadarshini Nayak (Aal Biosciences Research Private Limited), Dinesh Gupta (Aal Biosciences Research Private Limited), Sridhar Muthayala (Aal Biosciences Research Private Limited), Divya (S2i Institute Private Limited), Harishchandra Purnachandra Dash (O2a Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available